Assembly Bill A4233

2017-2018 Legislative Session

Relates to extending the preferred drug program to medicaid managed care providers and health plans; repealer

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

multi-Sponsors

2017-A4233 (ACTIVE) - Details

Current Committee:
Assembly Ways And Means
Law Section:
Social Services Law
Laws Affected:
Add §365-i, rpld §364-j subs 25 & 25-a, Soc Serv L; amd §§270 & 272, add §274-a, Pub Health L
Versions Introduced in Other Legislative Sessions:
2015-2016: A9271
2019-2020: A2795

2017-A4233 (ACTIVE) - Summary

Extends the preferred drug program to medicaid managed care providers and offers the program to other health plans.

2017-A4233 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   4233
 
                        2017-2018 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 1, 2017
                                ___________
 
 Introduced by M. of A. GOTTFRIED, THIELE, RODRIGUEZ, MOSLEY, MAGNARELLI,
   LUPARDO,  CRESPO,  BLAKE, GALEF, JAFFEE, SEAWRIGHT, MONTESANO, TITONE,
   GUNTHER, LIFTON, SEPULVEDA, HOOPER, DINOWITZ, OTIS,  JENNE,  ABINANTI,
   HYNDMAN,  ORTIZ  --  Multi-Sponsored  by  --  M.  of A. CARROLL, COOK,
   CROUCH, ENGLEBRIGHT, GLICK, SIMON -- read once  and  referred  to  the
   Committee on Health
 
 AN  ACT  to  amend the social services law and the public health law, in
   relation to extending the preferred drug program to  medicaid  managed
   care  providers and offering the program to other health plans; and to
   repeal certain provisions of the social services law relating thereto
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Legislative findings. This legislature finds that the costs
 of  many prescription drugs in the market have been escalating unreason-
 ably. The preferred drug program and the clinical  drug  review  program
 under  the  public  health law provide effective mechanisms for assuring
 access to quality, effective and safe drugs to  patients  at  reasonable
 cost.  Providing  prescription  drugs  to  Medicaid  managed health care
 provider participants through these programs will maximize the  Medicaid
 program's  ability  to  negotiate  more  substantial  rebates  with drug
 manufacturers (effectively, lower  prices),  while  protecting  Medicaid
 managed  care  provider participants. Offering non-Medicaid health plans
 the opportunity to use these programs will help lower  costs  for  those
 health plans and those who pay their premiums, while protecting individ-
 uals  covered by those plans, and will also further increase the negoti-
 ating power of the programs.
   § 2. The social services law is amended by adding a new section  365-i
 to read as follows:
   §  365-I.  PRESCRIPTION  DRUGS  IN MEDICAID MANAGED CARE PROGRAMS.  1.
 DEFINITIONS. (A) THE DEFINITIONS OF TERMS IN SECTION TWO HUNDRED SEVENTY
 OF THE PUBLIC HEALTH LAW SHALL APPLY TO THIS SECTION.
   (B) AS USED IN THIS  SECTION,  UNLESS  THE  CONTEXT  CLEARLY  REQUIRES
 OTHERWISE:
 
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.